Skip to main content

Articles

Page 7 of 60

  1. Sampson et al. developed a novel method to estimate very low-density lipoprotein cholesterol (VLDL-C) and low-density lipoprotein cholesterol (LDL-C) in the setting of hypertriglyceridemia. Familial Combined H...

    Authors: Arsenio Vargas-Vázquez, Omar Yaxmehen Bello-Chavolla, Neftali Eduardo Antonio-Villa, Roopa Mehta, Ivette Cruz-Bautista and Carlos A. Aguilar-Salinas
    Citation: Lipids in Health and Disease 2021 20:46
  2. Although patients with familial heterozygous hypercholesterolemia (FH) have a high risk of early myocardial infarction (MI), the coronary artery disease (CAD) burden in FH patients with acute MI remains to be ...

    Authors: Hermann Yao, Michel Farnier, Laura Tribouillard, Frédéric Chague, Philippe Brunel, Maud Maza, Damien Brunet, Luc Rochette, Florence Bichat, Yves Cottin and Marianne Zeller
    Citation: Lipids in Health and Disease 2021 20:45
  3. Johann Ludwig Wilhelm Thudicum described sphingolipids (SLs) in the late nineteenth century, but it was only in the past fifty years that SL research surged in importance and applicability. Currently, sphingol...

    Authors: Muna Abed Rabbo, Yara Khodour, Laurie S. Kaguni and Johnny Stiban
    Citation: Lipids in Health and Disease 2021 20:44
  4. Waist circumference (WC) and uric acid (UA) are significantly related. Still, their temporal sequence and how the sequence works on future risk of triglyceride glucose (TyG) are unknown, especially in the Chin...

    Authors: Jia Zheng, Min Jiang and Yanxia Xie
    Citation: Lipids in Health and Disease 2021 20:42
  5. Recently, several novel scoring systems have been developed to evaluate the severity and outcomes of acute pancreatitis. This study aimed to compare the effectiveness of novel and conventional scoring systems ...

    Authors: Qing Wu, Jie Wang, Mengbin Qin, Huiying Yang, Zhihai Liang and Guodu Tang
    Citation: Lipids in Health and Disease 2021 20:41
  6. Nonalcoholic fatty liver disease (NAFLD) can lead to chronic liver diseases associated with mitochondrial damages. However, the exact mechanisms involved in the etiology of the disease are not clear.

    Authors: Yan Jiang, Duankai Chen, Qiming Gong, Qunqing Xu, Dong Pan, Feiyan Lu and Qianli Tang
    Citation: Lipids in Health and Disease 2021 20:40
  7. To investigate the roles of the transcription factors twist family bHLH transcription factor 1 (TWIST1), twist family bHLH transcription factor 2 (TWIST2), and peroxisome proliferator activated receptor gamma ...

    Authors: Yanmei Zhang, Xiaoxiao Ge, Yongqing Li, Bingyang Zhang, Peijun Wang, Mingju Hao, Peng Gao, Yueyi Zhao, Tao Sun, Sumei Lu and Wanshan Ma
    Citation: Lipids in Health and Disease 2021 20:39
  8. Neonatal severe hypertriglyceridemia is rarely reported in the literature and there is no consensus for hypertriglyceridemia management at this age group.

    Authors: Nehal M. El-koofy, Yasmeen A. Abdo, Dina El-Fayoumi, Amanne F. Esmael, Mohamed. A. Elmonem and Zahraa Ezzeldin
    Citation: Lipids in Health and Disease 2021 20:38
  9. Some observational studies have found a significant association between the use of statin and a reduced risk of dementia. However, the results of these studies are unclear in patients with rheumatoid arthritis...

    Authors: Tsung-Kun Lin, Jing-Yang Huang, Lung-Fa Pan and Gwo-Ping Jong
    Citation: Lipids in Health and Disease 2021 20:37
  10. Several studies have found that a low baseline low -density lipoprotein cholesterol (LDL-C) concentration was associated with poor prognosis in patients with acute coronary syndrome (ACS), which is called the ...

    Authors: Bo Wang, Jin Liu, Shiqun Chen, Ming Ying, Guanzhong Chen, Liwei Liu, Zhubin Lun, Huanqiang Li, Haozhang Huang, Qiang Li, Yaren Yu, Mengfei Lin, Wen Wei, Zhidong Huang, Yongquan Yang, Jiyan Chen…
    Citation: Lipids in Health and Disease 2021 20:36
  11. The inflammatory response plays essential roles in the pathological process and prognosis of Parkinson’s disease (PD). This research investigated the predictive value of the neutrophil to high-density lipoprot...

    Authors: Zhu Liu, Qingli Fan, Shizheng Wu, Yaqi Wan and Yancheng Lei
    Citation: Lipids in Health and Disease 2021 20:35
  12. Polycystic ovary syndrome (PCOS) is associated with obesity, diabetes, and insulin resistance. The circulating C1Q/TNF-related proteins (CTRP-2, CTRP-9) and growth differentiation factors (GDF-8, GDF-15) contr...

    Authors: Jayakumar Jerobin, Manjunath Ramanjaneya, Ilham Bettahi, Raihanath Parammal, Kodappully Sivaraman Siveen, Meis Alkasem, Myint Aye, Thozhukat Sathyapalan, Monica Skarulis, Stephen L. Atkin and Abdul Badi Abou-Samra
    Citation: Lipids in Health and Disease 2021 20:34
  13. Cardiovascular disease (CVD) is a major cause of mortality and morbidity within the Asia-Pacific region, with the prevalence of CVD risk factors such as plasma lipid disorders increasing in many Asian countrie...

    Authors: Zhen-Vin Lee, Elmer Jasper Llanes, Renan Sukmawan, Nuntakorn Thongtang, Huynh Quang Tri Ho and Philip Barter
    Citation: Lipids in Health and Disease 2021 20:33
  14. Lysophosphatidic acid (LPA) is a bioactive lysophospholipid that acts through its six cognate G protein-coupled receptors. As a family, lysophospholipids have already produced medicines (e.g., sphingosine 1-phosp...

    Authors: Manisha Ray, Yasuyuki Kihara, Darryl J. Bornhop and Jerold Chun
    Citation: Lipids in Health and Disease 2021 20:32
  15. Hyperhomocysteinemia (HHcy) is associated with various health problems, but less is known about the gender differences in risk factors for high plasma homocysteine (Hcy) levels.

    Authors: Jing Zhao, Zhihua Li, Chengbei Hou, Fei Sun, Jing Dong, Xi Chu and Yansu Guo
    Citation: Lipids in Health and Disease 2021 20:31
  16. Developing an understanding of the biochemistry of aging in both sexes is critical for managing disease throughout the lifespan. Lipidomic associations with age and sex have been reported, but prior studies ar...

    Authors: Emily Slade, Marguerite R. Irvin, Kevin Xie, Donna K. Arnett, Steven A. Claas, Tobias Kind, David W. Fardo and Gregory A. Graf
    Citation: Lipids in Health and Disease 2021 20:30
  17. This study aimed to investigate the prevalence, awareness, treatment, and control rates of dyslipidemia and identify the predictors of optimal control (low-density lipoprotein cholesterol < 100 mg/dL) among pa...

    Authors: Seung Jae Kim, Oh. Deog Kwon and Kyung-Soo Kim
    Citation: Lipids in Health and Disease 2021 20:29
  18. Low-density lipoprotein to high density lipoprotein (LDL/HDL) cholesterol ratio has been reported to predict the risk of many metabolic diseases. However, the association between the LDL/HDL cholesterol ratio ...

    Authors: Yang Zou, Ling Zhong, Chong Hu, Mingchun Zhong, Nan Peng and Guotai Sheng
    Citation: Lipids in Health and Disease 2021 20:28
  19. The performance of liver stiffness measurements (LSMs) obtained using FibroScan can be affected by several factors, and cut-off values are different for fibrosis caused by various aetiologies. The study aims t...

    Authors: Xinyu Yang, Xinxia Chang, Shengdi Wu, Xiaoyang Sun, Xiaopeng Zhu, Liu Wang, Yushan Xu, Xiuzhong Yao, Shengxiang Rao, Xiqi Hu, Mingfeng Xia, Hua Bian, Hongmei Yan and Xin Gao
    Citation: Lipids in Health and Disease 2021 20:27
  20. To investigate the correlation between the thickness of epicardial adipose tissue (EAT), C-reactive protein (CRP), interleukin (IL) -6, visfatin, juxtaposed with another zinc finger protein 1 (JAZF1) and type ...

    Authors: Yuan-Yuan Gong and Hai-Ying Peng
    Citation: Lipids in Health and Disease 2021 20:25
  21. Dietary sphingolipids have various biofunctions, including skin barrier improvement and anti-inflammatory and anti-carcinoma properties. Long-chain bases (LCBs), the essential backbones of sphingolipids, are e...

    Authors: Daisuke Mikami, Shota Sakai, Megumi Nishimukai, Kohei Yuyama, Katsuyuki Mukai and Yasuyuki Igarashi
    Citation: Lipids in Health and Disease 2021 20:24
  22. Although imbalanced intestinal flora contributes to the pathogenesis of nonalcoholic fatty liver disease (NAFLD), conflicting results have been obtained for patient-derived microbiome composition analyses. A m...

    Authors: Fuxi Li, Junzhao Ye, Congxiang Shao and Bihui Zhong
    Citation: Lipids in Health and Disease 2021 20:22
  23. PCSK9 monoclonal antibody lowers plasma PCSK9 and LDL-cholesterol levels. The manufacturers recommend drug storage at 2–8 °C, and not above 25 °C. This study aimed to investigate drug stability at various temp...

    Authors: Tanawan Kongmalai, Nalinee Chuanchaiyakul, Chattip Sripatumtong, Tunsuda Tansit, Yuttana Srinoulprasert, Nareerak Klinsukon and Nuntakorn Thongtang
    Citation: Lipids in Health and Disease 2021 20:21
  24. High-density lipoprotein cholesterol (HDL-C) hypolipidemia, a major type of dyslipidemia, has been associated with many kinds of diseases, such as stroke, coronary heart disease, obesity and diabetes, and has ...

    Authors: Fang Tang, Jian Wang, Stephen Nicholas, Dongfu Qian and Rugang Liu
    Citation: Lipids in Health and Disease 2021 20:20
  25. Poor cholesterol efflux capacity (CEC) has been proposed to be an independent risk factor for cardiovascular diseases. However, current evidence is inconsistent, especially in rheumatoid arthritis (RA) patient...

    Authors: Binbin Xie, Jiang He, Yong Liu, Ting Liu and Chaoqun Liu
    Citation: Lipids in Health and Disease 2021 20:18
  26. Pemafibrate, a selective PPARα modulator, has the beneficial effects on serum triglycerides (TGs) and very low density lipoprotein (VLDL), especially in patients with diabetes mellitus or metabolic syndrome. H...

    Authors: Ichiro Komiya, Akira Yamamoto, Suguru Sunakawa and Tamio Wakugami
    Citation: Lipids in Health and Disease 2021 20:17
  27. Psoriasis is a common chronic inflammatory skin disease associated with overproduction of interleukin-17A (IL-17A). IL-17A monoclonal antibodies (mAbs) have shown clinical efficacy in psoriasis patients. Altho...

    Authors: Han Cao, Shengmin Su, Qi Yang, Yunchen Le, Lihong Chen, Mengyan Hu, Xiaoyu Guo, Jie Zheng, Xia Li and Yunqiu Yu
    Citation: Lipids in Health and Disease 2021 20:16
  28. The association of circulating lipids with clinical outcomes of drug-resistant castration-resistant prostate cancer (DR-CRPC) is not fully understood. While it is known that increases in select lipids correlat...

    Authors: Lishann M. Ingram, Morgan C. Finnerty, Maryam Mansoura, Chau-Wen Chou and Brian S. Cummings
    Citation: Lipids in Health and Disease 2021 20:15
  29. Familial hypertriglyceridemia (FHTG) is a partially characterized primary dyslipidemia which is frequently confused with other forms hypertriglyceridemia. The aim of this work is to search for specific feature...

    Authors: Ivette Cruz-Bautista, Alicia Huerta-Chagoya, Hortensia Moreno-Macías, Rosario Rodríguez-Guillén, María Luisa Ordóñez-Sánchez, Yayoi Segura-Kato, Roopa Mehta, Paloma Almeda-Valdés, Lizeth Gómez-Munguía, Ximena Ruiz-De Chávez, Ximena Rosas-Flota, Arali Andrade-Amado, Bárbara Bernal-Barroeta, María Guadalupe López-Carrasco, Luz Elizabeth Guillén-Pineda, Angelina López-Estrada…
    Citation: Lipids in Health and Disease 2021 20:14
  30. Dyslipidemia contributes to the pathogenesis of renal dysfunction. Previous research demonstrated that triglycerides (TG), instead of other individual lipid indexes, has a significant link with elevated urinar...

    Authors: Jing Xue, Yuxia Wang, Bing Li, Songyan Yu, Anping Wang, Weiqing Wang, Zhengnan Gao, Xulei Tang, Li Yan, Qin Wan, Guijun Qin, Lulu Chen, Guang Ning and Yiming Mu
    Citation: Lipids in Health and Disease 2021 20:13
  31. Lipoprotein-associated Phospholipase A2 (Lp-PLA2), can exert proinflammatory as well as proatherogenic properties on the vascular wall. The current study sought to evaluate the influence of high Lp-PLA2 levels...

    Authors: Konstantinos Mourouzis, Gerasimos Siasos, Evangelos Oikonomou, Marina Zaromitidou, Vicky Tsigkou, Alexis Antonopoulos, Evanthia Bletsa, Panagiota Stampouloglou, Konstantinos Vlasis, Manolis Vavuranakis and Dimitris Tousoulis
    Citation: Lipids in Health and Disease 2021 20:12
  32. Few studies have developed risk models for dyslipidaemia, especially for rural populations. Furthermore, the performance of genetic factors in predicting dyslipidaemia has not been explored. The purpose of thi...

    Authors: Miaomiao Niu, Liying Zhang, Yikang Wang, Runqi Tu, Xiaotian Liu, Jian Hou, Wenqian Huo, Zhenxing Mao, Zhenfei Wang and Chongjian Wang
    Citation: Lipids in Health and Disease 2021 20:11
  33. Hypertriglyceridemia has arisen as the third leading cause of acute pancreatitis. This study aimed at exploring the association between the severity of hypertriglyceridemia-induced pancreatitis (HTGP) and comp...

    Authors: Lifang Chen, Yingbao Huang, Huajun Yu, Kehua Pan, Zhao Zhang, Yi Man and Dingyuan Hu
    Citation: Lipids in Health and Disease 2021 20:9
  34. An amendment to this paper has been published and can be accessed via the original article.

    Authors: Xiaoli Li, Guilong Li, Tiantian Cheng, Jing Liu, Guangyao Song and Huijuan Ma
    Citation: Lipids in Health and Disease 2021 20:8

    The original article was published in Lipids in Health and Disease 2020 19:236

  35. Polycystic Ovarian Syndrome (PCOS) is one of the most common endocrinopathies and metabolic disorders in women during their reproductive years. It is often associated with dyslipidemia and other risk factors o...

    Authors: Maryam Yahay, Zahra Heidari, Zahra Allameh and Reza Amani
    Citation: Lipids in Health and Disease 2021 20:7
  36. Proprotein convertase subtilisin/kexin type 9 (PCSK9) is of particular importance in cholesterol metabolism with high levels contributing to hypercholesterolemia. Cholesterol and sphingolipids are low in patie...

    Authors: Susanne Feder, Reiner Wiest, Thomas S. Weiss, Charalampos Aslanidis, Doris Schacherer, Sabrina Krautbauer, Gerhard Liebisch and Christa Buechler
    Citation: Lipids in Health and Disease 2021 20:6
  37. Several large clinical trials have confirmed the cardioprotective role of sodium-glucose cotransporter 2 inhibitors (SGLT2i) in patients with type 2 diabetes. However, whether empagliflozin, as an SGLT2i, coul...

    Authors: Yihai Liu, Jiamin Xu, Mingyue Wu, Biao Xu and Lina Kang
    Citation: Lipids in Health and Disease 2021 20:5
  38. Familial hypercholesterolemia(FH) is one of the most frequent and important monogenic cholesterol pathologies. Traditional and non-traditional cardiovascular risk factors increase the prevalence of atheroscler...

    Authors: Cristiana-Elena Vlad, Liliana Foia, Laura Florea, Irina-Iuliana Costache, Andreea Covic, Roxana Popescu, Delia Reurean-Pintilei and Adrian Covic
    Citation: Lipids in Health and Disease 2021 20:4
  39. Dyslipidemia is considered an independent health risk factor of cardiovascular disease (CVD), a leading cause of mortality in older adults. Despite its importance, there have been few reports on the associatio...

    Authors: Seung Hee Kim and Ki Young Son
    Citation: Lipids in Health and Disease 2021 20:3
  40. Clinical trials have demonstrated that either initiating or up-titrating a statin dose substantially reduce Low-Density Lipoprotein-Cholesterol (LDL-C) levels. However, statin adherence in actual practice tend...

    Authors: Hao Sen Andrew Fang, Qiao Gao, Mong Li Lee, Wynne Hsu and Ngiap Chuan Tan
    Citation: Lipids in Health and Disease 2021 20:2
  41. Elevated triglyceride (TG) levels are a biomarker for cardiovascular disease (CVD) risk. The correlation between serum uric acid (SUA) and TG concentrations in adults or obese children is well established. How...

    Authors: Yuntian Chu, Qianqian Zhao, Mei Zhang, Bo Ban and Hongbing Tao
    Citation: Lipids in Health and Disease 2021 20:1
  42. Nonalcoholic steatohepatitis (NASH) is a form of liver disease characterized by steatosis, necroinflammation, and fibrosis, resulting in cirrhosis and cancer. Efforts have focused on reducing the intake of trans ...

    Authors: Noriko Suzuki-Kemuriyama, Akari Abe, Kinuko Uno, Shuji Ogawa, Atsushi Watanabe, Ryuhei Sano, Megumi Yuki, Katsuhiro Miyajima and Dai Nakae
    Citation: Lipids in Health and Disease 2020 19:251

    The Correction to this article has been published in Lipids in Health and Disease 2022 21:2

  43. Emerging data support a role for lipids in non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma (HCC) in humans. With experimental models such data can be challenged or validated. Mice fed a low-m...

    Authors: Elisabeth M. Haberl, Rebekka Pohl, Lisa Rein-Fischboeck, Marcus Höring, Sabrina Krautbauer, Gerhard Liebisch and Christa Buechler
    Citation: Lipids in Health and Disease 2020 19:250
  44. Lipoproteins at aberrant levels are known to play a role in cardiovascular disease. The metabolite of the insecticide dichlorodiphenyltrichloroethane (DDT), p,p’-dichlorodiphenyldichloroethylene (p,p’-DDE), ph...

    Authors: Juliann Jugan, P. Monica Lind, Samira Salihovic, Jordan Stubleski, Anna Kärrman, Lars Lind and Michele A. La Merrill
    Citation: Lipids in Health and Disease 2020 19:249
  45. A study conducted on elderly Korean men showed that a high serum triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio was associated with a high risk of developing sarcopenia. We aimed to dete...

    Authors: Na Wang, Mengjun Chen and Danhong Fang
    Citation: Lipids in Health and Disease 2020 19:248

Annual Journal Metrics